Seminars in Nuclear Medicine
Volume 34, Issue 4 , Pages 293-299 , October 2004

The role of positron emission tomography in radiation treatment planning

  • Steven Bujenovic, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Steven Bujenovic, MD, Nuclear Medicine Associates, LLC, 8241 Summa Ave, Suite D, Baton Rouge, LA 70809.

References 

  1. Schmidt DT, Eyrich GK, Graetz KW, et al: Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Society of nuclear medicine 50th annual meeting, New Orleans, LA, 2003 (abstract)
  2. Bujenovic L: FDG-PET in patients with head and neck carcinoma: Incidence of distant metastases in patients and the clinical impact on radiation planning. Society nuclear medicine 50th annual meeting, New Orleans, LA, 2003 (abstract)
  3. Boucher L , Rodrigue S , Lecomte R , et al.   Respiratory gating for 3-dimensional PET of the thorax (Feasibility and initial results) . J Nuc Med . 2004;45:214–219
  4. De Juan R , Seifert B , Berthold T , et al.   Clinical evaluation of a breathing protocol for PET/CT . Eur Radiol . 2004;14: 1118-1112
  5. Goerres G , Hany T , Ehab K , et al.   Head and neck imaging with PET and PET/CT (Artefacts from dental metallic implants) . Eur J Nuc Med Mol Imaging . 2002;29:367–370
  6. Bujenovic L , Mannting F , Chakrabarti R , et al.   Artifactual 2-deoxy-2-[(18)F]fluoro-D-glucose localization surrounding metallic objects in a PET/CT scanner, using CT-based attenuation correction . Mol Imaging Biol . 2003;5:20–22
  7. Cohade C , Wahl R . Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography—clinical use, interpretation methods, diagnostic improvements . Semin Nucl Med . 2003;33:228–237
  8. Antoch G , Freudenberg L , Beyer T , et al.   To enhance or not to enhance? F18-FDG and CT contrast agents in dual modality, F-18 FDG PET/CT . J Nucl Med . 2004;45(suppl 1):56S–65S
  9. ICRU report; 62. prescribing, recording and reporting photon beam therapy: (Suppl to ICRU report 50), 1999
  10. Rubin P . Clinical Oncology (ed 8) . Philadelphia, PA: Saunders; 2001;
  11. Saijo N . Progress in treatment of small-cell lung cancer (Role of CPT-11) . Br J Cancer . 2003;89:2178–2183
  12. Eberhardt W , Albain K , Pass H , et al.   Induction treatment before surgery for non-small cell lung cancer . Lung Cancer . 2003;12(suppl 1):59
  13. Pottgen C , Eberhardt W , Stuschke M . Prophylactic cranial irradiation in lung cancer . Curr Treat Options Oncol . 2004;5:43–50
  14. Rigo P , Hustinx R , Bury T . PET imaging in lung cancer . In:  Valk PE ,  Bailey DL ,  Townsend DW ,  Maisey MN editor. Positron Emission and Tomography (Basic Science and Clinical Practice) . London, UK: Springer; 2003;p. 517–534
  15. Gupta NC , Wuel TJ , Graeber GC , et al.   Mediastinal lymph node sampling following positron emission tomography with fluorodeoxy-glucose imaging in lung cancer staging . Chest . 2001;120:521–527
  16. Vansteenkiste JF , Stroobants SG , DeLeyn PR , et al.   Lymph node staging in non-small cell lung cancer with FDG-PET (A prospective study on 690 lymph node stations from 68 patients) . J Clin Oncol . 1998;16:2142–2149
  17. Pieterman R , van Putten J , Meuzlaar J , et al.   Preoperative staging of non-small cell lung cancer with positron emission tomography . N Engl J Med . 2000;343:254–261
  18. Steinert H , Hauser M , Allemann F , et al.   Non-small cell lung cancer (Nodal staging with FDG PET versus CT with correlative lymph node mapping in sampling) . Radiology . 1997;202:441–446
  19. Yun M , Kim W , Alnafisi N , et al.   18F-FDG PET in characterizing adrenal lesions detected on CT or MRI . J Nucl Med . 2001;42:1795–1799
  20. Valk P , Pounds T , Hopkins D , et al.   Staging nonsmall cell lung cancer by whole body positron emission tomography imaging . Ann Thoracic Surg . 1995;60:1573–1582
  21. Kalff V , Hicks RJ , MacManus MP , et al.   Clinical impact of (18)F fluoro-deoxyglucose positron emission tomography in patients with non-small-cell lung cancer (A prospective study) . J Clin Oncol . 2001;19:111–118
  22. Hicks RJ , Kalff V , MacManus MP , et al.   (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small-cell lung cancer . J Nucl Med . 2001;42:1596–1604
  23. Mesurolle B , Mignon F , Meingan P , et al.   Head and neck cancer patients with pulmonary nodules (value and role of CT-guided transthoracic needle aspiration biopsies) . Head Neck . 2003;25:889–894
  24. Erasums J , Patz E . Positron emission tomography imaging in the thorax . Clin Chest Med . 1999;20:715–724
  25. Jones A , Fish B , Fenton J , et al.   The treatment of early laryngeal carncers (T1T2 N0) (Surgery or irradiation?) . Head Neck . 2004;26:127–135
  26. Sessions D , Lenox J , Specter G , et al.   Analysis of treatment results for base of tongue cancer . Laryngoscope . 2003;113:1252–1261
  27. Wong W , Saunders M . The impact of FDG PET on the management of occult primary head and neck tumors . Clin Oncol . 2003;15:461–466
  28. Stuckensen T , Kovacs A , Adams S , et al.   Staging of the neck in patients with oral cavity squamous cell carcinomas (a prospective comparison of PET, ultrasound, CT and MRI) . J Craniomaxillofac Surg . 2000;28:319–324
  29. Stoeckli S , Steinert M , Pfaltz M , et al.   Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinomas? . Head Neck . 2002;24:345–349
  30. Rege S , Safa AA , Chaiken L , et al.   Positron emission tomography (an independent indicator of radiocurability in head and neck carcinomas) . Am J Clin Oncol . 2000;23:164–169
  31. Lonneux M , Lawson G , Ide C , et al.   Positron emission tomography with fluoro- deoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient . Laryngoscope . 2000;110:1493–1497
  32. Lowe VJ , Dunphy FR , Varvares M , et al.   Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography . Nead Neck . 1997;19:666–674
  33. Kitagawa Y , Sadato N , Azuma H , et al.   18F-FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms . J Nucl Med . 1999;40:1132–1137
  34. Yahalom J . Changing role and decreasing size (current trends in radiotherapy for Hodgkin’s disease) . Curr Oncol Rep . 2002;4:415–423
  35. Yahalom J, Mauch P: The involved field is back: issues in delineating the radiation field in Hodgkin’s disease. Ann Oncol Supplement 1:79–83
  36. Strumpe K , Urbinelli M , Steinert H , et al.   Whole body positron emission tomography using fluorodeoxyglucose for staging lymphoma (Effectiveness and comparison with computed tomography) . Eur J Nucl Med . 1998;25:721–728
  37. Lavely WC , Delbeke D , Greer JP , et al.   FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy . Int J Radiat Oncol Biol Phys . 2003;57:307–315
  38. Minsky BD . Adjuvant therapy for rectal cancer–the transatlantic view . Colorectal Dis . 2003;5:416–422
  39. Kachnic LA , Shih HA , Willett CG . Advances in combined radiation therapy for the management of rectal cancer . Expert Rev Anticancer Ther . 2003;3:471–483
  40. Moertel CG , Fleming TR , Macdonald JS , et al.   An evaluation of the carcino-embryonic antigen (CEA) test for monitoring patients with resected colon cancer . JAMA . 1993;270:943–947
  41. Huebner R , Park KC , Shepard J , et al.   Meta-analysis of the literature for whole body FDG PET detection of recurrent colorectal cancer . J Nucl Med . 2000;41:1177–1189
  42. Vrdoljak E , Hamm W . Current state-of-the-art of concomitant chemoradiation in cervical carcinomas . Eur J Gynaecol Oncol . 2003;24:475–479
  43. Hockel M . Surgical treatment of locally advanced and recurrent cervical carcinoma (Overview on current standard and new developments) . Onkologie . 2003;26:452–455
  44. Waggoner SE . Cervical cancer . Lancet . 2003;361:2217–2225
  45. Narayan K , Hicks RJ , Jobling T , et al.   A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer (Potential impact on treatment) . Int J Gynecol Cancer . 2001;11:263–271
  46. Grigsby PW , Siegel BA , Dehdashti F , et al.   Posttherapy surveillance monitoring of cervical cancer by FDG-PET . Int J Radiat Oncol Biol Phys . 2003;55:907–913
  47. Wahl R . Principals and practice of positron emission tomography . Philadelphia, PA: Lippincott; 2002;
  48. Flanagan F , Dehdashi F , Siegel B , et al.   Staging of esophageal cancer with 18F- fluorodeoxyglucose positron emission tomography . Am J Roentgenol . 1997;168:417–424
  49. Flamen P , Lerut A , VanCutsen E , et al.   The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer . J Thorac Cardiovasc Surg . 2000;120:1085–1092
  50. Haney T , Steinert H , Goerres G , et al.   PET diagnostic accuracy: Improvement with in-line PET/CT system: Initial results . Radiology . 2002;225:575–581
  51. Dearling J , Flynn A , Sutcliffe-Goulden J , et al.   Analysis of the regional uptake of radiolabeled deoxyglucose analogues in human tumor xenographs . J Nucl Med . 2004;45:101–107
  52. Manoharan R, Ishihara Y, Bujenovic L: Rapid validation of PET/CT data sets for radiation treatment planning (RTP). Society of Nuclear Medicine 51st annual meeting, Philadelphia, PA, 2004 (abstract)
  53. Zabic S, Bujenovic L: A computer algorithm for gross tumor volume determination in PET/CT images for radiation treatment planning. Society of Nuclear Medicine 51st annual meeting, Philadelphia, PA, 2004 (abstract)

PII: S0001-2998(04)00043-1

doi: 10.1053/j.semnuclmed.2004.06.005

Seminars in Nuclear Medicine
Volume 34, Issue 4 , Pages 293-299 , October 2004

Article Tools